Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-29T11:25:39.720Z Has data issue: false hasContentIssue false
  • English
  • Français

Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus

Published online by Cambridge University Press:  01 June 2017

Richard E. Nelson ,
Rachel B. Slayton ,
Vanessa W. Stevens ,
Makoto M. Jones ,
Karim Khader ,
Michael A. Rubin ,
John A. Jernigan  and
Matthew H. Samore
Richard E. Nelson*
Affiliation:
Veterans Affairs Salt Lake City Health System IDEAS Center, Salt Lake City, Utah Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah
Rachel B. Slayton
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Vanessa W. Stevens
Affiliation:
Veterans Affairs Salt Lake City Health System IDEAS Center, Salt Lake City, Utah Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah
Makoto M. Jones
Affiliation:
Veterans Affairs Salt Lake City Health System IDEAS Center, Salt Lake City, Utah Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah
Karim Khader
Affiliation:
Veterans Affairs Salt Lake City Health System IDEAS Center, Salt Lake City, Utah Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah
Michael A. Rubin
Affiliation:
Veterans Affairs Salt Lake City Health System IDEAS Center, Salt Lake City, Utah Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah
John A. Jernigan
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Matthew H. Samore
Affiliation:
Veterans Affairs Salt Lake City Health System IDEAS Center, Salt Lake City, Utah Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah
*
Address correspondence to Richard E. Nelson, PhD, 500 Foothill Blvd, Salt Lake City, UT 84148 (richard.nelson@utah.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

The purpose of this study was to quantify the effect of multidrug-resistant (MDR) gram-negative bacteria and methicillin-resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAIs) on mortality following infection, regardless of patient location.

METHODS

We conducted a retrospective cohort study of patients with an inpatient admission in the US Department of Veterans Affairs (VA) system between October 1, 2007, and November 30, 2010. We constructed multivariate log-binomial regressions to assess the impact of a positive culture on mortality in the 30- and 90-day periods following the first positive culture, using a propensity-score–matched subsample.

RESULTS

Patients identified with positive cultures due to MDR Acinetobacter (n=218), MDR Pseudomonas aeruginosa (n=1,026), and MDR Enterobacteriaceae (n=3,498) were propensity-score matched to 14,591 patients without positive cultures due to these organisms. In addition, 3,471 patients with positive cultures due to MRSA were propensity-score matched to 12,499 patients without positive MRSA cultures. Multidrug-resistant gram-negative bacteria were associated with a significantly elevated risk of mortality both for invasive (RR, 2.32; 95% CI, 1.85–2.92) and noninvasive cultures (RR, 1.33; 95% CI, 1.22–1.44) during the 30-day period. Similarly, patients with MRSA HAIs (RR, 2.77; 95% CI, 2.39–3.21) and colonizations (RR, 1.32; 95% CI, 1.22–1.50) had an increased risk of death at 30 days.

CONCLUSIONS

We found that HAIs due to gram-negative bacteria and MRSA conferred significantly elevated 30- and 90-day risks of mortality. This finding held true both for invasive cultures, which are likely to be true infections, and noninvasive infections, which are possibly colonizations.

Infect Control Hosp Epidemiol 2017;38:848–856

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 38 , Issue 7 , July 2017 , pp. 848 - 856
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198–1208.CrossRefGoogle ScholarPubMed
2. Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013;34:1–14.Google Scholar
3. Peleg, AY, Hooper, DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010;362:1804–1813.Google Scholar
4. Schweizer, ML, Eber, MR, Laxminarayan, R, et al. Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol 2011;32:148–154.CrossRefGoogle ScholarPubMed
5. Umscheid, CA, Mitchell, MD, Doshi, JA, Agarwal, R, Williams, K, Brennan, PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011;32:101–114.Google Scholar
6. Waters, TM, Daniels, MJ, Bazzoli, GJ, et al. Effect of Medicare’s nonpayment for hospital-acquired conditions: lessons for future policy. JAMA Intern Med 2015;175:347–354.Google Scholar
7. Abbo, A, Carmeli, Y, Navon-Venezia, S, Siegman-Igra, Y, Schwaber, MJ. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 2007;26:793–800.Google Scholar
8. Daniels, TL, Deppen, S, Arbogast, PG, Griffin, MR, Schaffner, W, Talbot, TR. Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units. Infect Control Hosp Epidemiol 2008;29:1080–1083.Google Scholar
9. Grupper, M, Sprecher, H, Mashiach, T, Finkelstein, R. Attributable mortality of nosocomial Acinetobacter bacteremia. Infect Control Hosp Epidemiol 2007;28:293–298.Google Scholar
10. Playford, EG, Craig, JC, Iredell, JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007;65:204–211.Google Scholar
11. Sunenshine, RH, Wright, MO, Maragakis, LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007;13:97–103.Google Scholar
12. Neily, J, Mills, PD, Young-Xu, Y, et al. Association between implementation of a medical team training program and surgical mortality. JAMA 2010;304:1693–1700.Google Scholar
13. Jones, M, DuVall, SL, Spuhl, J, Samore, MH, Nielson, C, Rubin, M. Identification of methicillin-resistant Staphylococcus aureus within the nation’s Veterans Affairs medical centers using natural language processing. BMC Med Inform Decis Mak 2012;12:34.Google Scholar
14. Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–332.Google Scholar
15. Branch-Elliman, W, Strymish, J, Gupta, K. Development and validation of a simple and easy-to-employ electronic algorithm for identifying clinical methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2014;35:692–698.Google Scholar
16. Gagne, JJ, Glynn, RJ, Avorn, J, Levin, R, Schneeweiss, S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol 2011;64:749–759.CrossRefGoogle ScholarPubMed
17. Austin, PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011;46:399–424.Google Scholar
18. Wolkewitz, M, Beyersmann, J, Gastmeier, P, Schumacher, M. Efficient risk set sampling when a time-dependent exposure is present: matching for time to exposure versus exposure density sampling. Methods Inform Med 2009;48:438–443.Google Scholar
19. Eagye, KJ, Kuti, JL, Nicolau, DP. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa . Infect Control Hosp Epidemiol 2009;30:746–752.Google Scholar
20. Ababneh, M, Harpe, S, Oinonen, M, Polk, RE. Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:594–601.Google Scholar
21. Landman, D, Babu, E, Shah, N, et al. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother 2012;67:1427–1431.Google Scholar
22. Reddy, T, Chopra, T, Marchaim, D, et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother 2010;54:2235–2238.Google Scholar
23. Roberts, RR, Hota, B, Ahmad, I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009;49:1175–1184.Google Scholar
24. Borowsky, SJ, Cowper, DC. Dual use of VA and non-VA primary care. J Gen Intern Med 1999;14:274–280.Google Scholar
25. Hynes, DM, Koelling, K, Stroupe, K, et al. Veterans’ access to and use of Medicare and Veterans Affairs health care. Med Care 2007;45:214–223.Google Scholar
26. Liu, CF, Bolkan, C, Chan, D, Yano, EM, Rubenstein, LV, Chaney, EF. Dual use of VA and non-VA services among primary care patients with depression. J Gen Intern Med 2009;24:305–311.Google Scholar
27. Brooke, BS, Goodney, PP, Kraiss, LW, Gottlieb, DJ, Samore, MH, Finlayson, SR. Readmission destination and risk of mortality after major surgery: an observational cohort study. Lancet 2015;386:884–895.Google Scholar
28. Suissa, S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008;167:492–499.Google Scholar
Supplementary material: File

Nelson supplementary material

Tables S1-S3

Download Nelson supplementary material(File)
File 104.7 KB